Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 17, 2001

View Archived Issues

Bakuchiol has in vitro antimicrobial activity against oral pathogens

Past exposure to vaccines may reduce risk of Alzheimer's disease

Transition Therapeutics acquires intellectual property to methyldonor technology for MS

Garlic supplements shown to interfere with HIV medication

Endovasc's NRA moves towards clinical development

Genaissance and AstraZeneca sign genomics agreement

Atugen and Oxford GlycoSciences collaborate on target validation

Genzyme and Pharming reach agreement

Discovery and Quintiles form Surfaxin sales and marketing alliance

Pexelizumab collaboration reviewed; 5G1.1 progress updated

Enrollment ahead of schedule in ISAtx-247 phase II psoriasis trial

Adolor receives three SBIR grants for pain relief research

Genaera identifies and targets novel gene in asthma

Antiangiogenic agent SU-6668/TSU-68 particularly effective against breast cancer

Mechanism of SAANDs confirmed in breast cancer cells

New therapeutic option available to leukemia patients in the U.K.

CDRI-93/478: preclinical compound for hypertension and myocardial ischemia

FR-226807, a highly potent and selective PDE5 inhibitor, compares favorably with sildenafil

TRAIL active against primary CLL and WSU-CLL alone and in combination with chemotherapeutic agents

New malaria vaccine offers significant protection against Plasmodium falciparum

First small-molecule cancer targets selected from BMS-Exelixis collaboration

Potent DP receptor antagonists claimed by Merck Frosst for allergic conditions

Roche spin-off company patents new triazole antifungal agents

Aminophenoxyacetamides with neuroprotective properties synthesized at Suntory

Inhibitors of NHE-3 designed by Merck KGaA

Preparation and use of nonpeptide MetAP2 inhibitors reported by GSK

Potent and selective inhibitors of thrombin disclosed by Corvas in recent patent

Distinctive endocrine profile of abarelix compared with LHRH agonists in prostate cancer

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...